Stelios Vlachiotis

Publikationer
Populärvetenskap och samverkan

Artiklar

Article: NATURE COMMUNICATIONS. 2023;14(1):6527
Design, structure and plasma binding of ancestral β-CoV scaffold antigens
Hueting D; Schriever K; Sun R; Vlachiotis S; Zuo F; Du L; Persson H; Hofstrom C; Ohlin M; Wallden K; Buggert M; Hammarstrom L; Marcotte H; Pan-Hammarstroem Q; Andrell J; Syren P-O
Article: NATURE COMMUNICATIONS. 2022;13(1):2670
Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant
Zuo F; Abolhassani H; Du L; Piralla A; Bertoglio F; de Campos-Mata L; Wan H; Schubert M; Cassaniti I; Wang Y; Sammartino JC; Sun R; Vlachiotis S; Bergami F; Kumagai-Braesch M; Andrell J; Zhang Z; Xue Y; Wenzel EV; Calzolai L; Varani L; Rezaei N; Chavoshzadeh Z; Baldanti F; Hust M; Hammarstrom L; Marcotte H; Pan-Hammarstrom Q
Article: ISCIENCE. 2022;25(2):103743
Immunity to SARS-CoV-2 up to 15 months after infection
Marcotte H; Piralla A; Zuo F; Du L; Cassaniti I; Wan H; Kumagai-Braesh M; Andrell J; Percivalle E; Sammartino JC; Wang Y; Vlachiotis S; Attevall J; Bergami F; Ferrari A; Colaneri M; Vecchia M; Sambo M; Zuccaro V; Asperges E; Bruno R; Oggionni T; Meloni F; Abolhassani H; Bertoglio F; Schubert M; Calzolai L; Varani L; Hust M; Xue Y; Hammarstrom L; Baldanti F; Pan-Hammarstrom Q
Article: CLINICAL IMMUNOLOGY. 2019;209:108265
Independent association of low IFNλ1 gene expression and type I IFN score/IFNλ1 ratio with obstetric manifestations and triple antiphospholipid antibody positivity in primary antiphospholipid syndrome.
Flessa C-M; Vlachiotis S; Nezos A; Andreakos E; Mavragani CP; Tektonidou MG

Alla övriga publikationer

Letter: THE LANCET REGIONAL HEALTH. WESTERN PACIFIC. 2023;33:100762
Heterologous inactivated virus/mRNA vaccination response to BF.7, BQ.1.1, and XBB.1
Zuo F; Sun R; Abolhassani H; Du L; Wang Y; Vlachiotis S; Bertoglio F; Schubert M; Rezaei N; Chavoshzadeh Z; Guerra C; Cavalli A; Andrell J; Kumagai-Braesch M; Xue Y; Cao Y; Hust M; Robbiani DF; Xie XS; Hammarstrom L; Marcotte H; Pan-Hammarstrom Q
Preprint: MEDRXIV. 2023
Heterologous inactivated virus/mRNA vaccination response to BF.7, BQ.1.1, and XBB.1
Zuo F; Sun R; Abolhassani H; Du L; Wang Y; Vlachiotis S; Bertoglio F; Schubert M; Rezaei N; Chavoshzadeh Z; Guerra C; Cavalli A; Andréll J; Kumagai-Braesch M; Xue Y; Cao Y; Hust M; Robbiani D; Xie XS; Hammarström L; Marcotte H; Pan-Hammarström Q
Review: EXPERT REVIEW OF CLINICAL IMMUNOLOGY. 2022;18(11):1145-1154
Transcriptional regulation of B cell class-switch recombination: the role in development of noninfectious complications
Vlachiotis S; Abolhassani H
Preprint: MEDRXIV. 2022
Heterologous immunization with inactivated vaccine followed by mRNA booster elicits strong humoral and cellular immune responses against the SARS-CoV-2 Omicron variant
Zuo F; Abolhassani H; Du L; Piralla A; Bertoglio F; de Campos-Mata L; Wan H; Schubert M; Wang Y; Sun R; Cassaniti I; Vlachiotis S; Kumagai-Braesch M; Andréll J; Zhang Z; Xue Y; Wenzel EV; Calzolai L; Varani L; Rezaei N; Chavoshzadeh Z; Baldanti F; Hust M; Hammarström L; Marcotte H; Pan-Hammarström Q
Preprint: BIORXIV. 2021
Immunity to SARS-CoV-2 up to 15 months after infection
Marcotte H; Piralla A; Zuo F; Du L; Cassaniti I; Wan H; Kumagai-Braesh M; Andréll J; Percivalle E; Sammartino JC; Wang Y; Vlachiotis S; Attevall J; Bergami F; Ferrari A; Colaneri M; Vecchia M; Sambo M; Zuccaro V; Asperges E; Bruno R; Oggionni T; Meloni F; Abolhassanni H; Bertoglio F; Schubert M; Calzolai L; Varani L; Hust M; Xue Y; Hammarström L; Baldanti F; Pan-Hammarström Q
Review: JOURNAL OF AUTOIMMUNITY. 2019;104:102319
Lambda interferons in immunity and autoimmunity.
Vlachiotis S; Andreakos E

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI